Summary:
- This preprint article describes the development of a new gene editing technology called "CRISPR-Trifecta" that can precisely target and modify multiple genomic regions simultaneously.
- The authors demonstrate the enhanced efficiency and specificity of CRISPR-Trifecta compared to traditional CRISPR systems in various cell lines and animal models, with potential applications in gene therapy and disease treatment.
- The study highlights the advancements in gene editing tools and their potential to revolutionize the field of genomic engineering and precision medicine.